Daniel J. Abdun-Nabi
2018
In 2018, Daniel J. Abdun-Nabi earned a total compensation of $4.1M as Former Chief Executive Officer at Emergent BioSolutions, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $980,394 |
|---|---|
| Option Awards | $955,226 |
| Salary | $829,160 |
| Stock Awards | $1,327,473 |
| Other | $8,683 |
| Total | $4,100,936 |
Abdun-Nabi received $1.3M in stock awards, accounting for 32% of the total pay in 2018.
Abdun-Nabi also received $980.4K in non-equity incentive plan, $955.2K in option awards, $829.2K in salary and $8.7K in other compensation.
Rankings
In 2018, Daniel J. Abdun-Nabi's compensation ranked 2,703rd out of 14,244 executives tracked by ExecPay. In other words, Abdun-Nabi earned more than 81.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,703 out of 14,244 | 81st |
Division Manufacturing | 1,002 out of 5,765 | 83rd |
Major group Chemicals And Allied Products | 349 out of 2,128 | 84th |
Industry group Drugs | 286 out of 1,817 | 84th |
Industry Pharmaceutical Preparations | 221 out of 1,391 | 84th |
Source: SEC filing on April 9, 2020.
Abdun-Nabi's colleagues
We found six more compensation records of executives who worked with Daniel J. Abdun-Nabi at Emergent BioSolutions in 2018.
2018
Fuad El-Hibri
Emergent BioSolutions
Chairman
2018
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2018
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2018
Atul Saran
Emergent BioSolutions
General Counsel
2018
Adam Havey
Emergent BioSolutions
Executive Vice President, Business Operations
2018
Richard Lindahl
Emergent BioSolutions